Search Clinical Trials
598,193 trials
ID
Status
Phase
Title
Sponsor
NCT07763275
Autologous Nanofat for Treatment of Atrophic ScarsBenha UniversityCompletedNot Applicable
NCT07763275Completed
Not Applicable
Autologous Nanofat for Treatment of Atrophic ScarsBenha University
NCT07762508
A Prospective Single-Arm Study of VABu Conditioning Regimen in Allo-HSCT for Low-Performance or High-Comorbidity AML Patients in CR1The First Affiliated Hospital of Soochow UniversityNot Yet RecruitingNot Applicable
NCT07762508Not Yet Recruiting
Not Applicable
A Prospective Single-Arm Study of VABu Conditioning Regimen in Allo-HSCT for Low...The First Affiliated Hosp...
NCT07762495
Echocardiographic Molecular Imaging for POC Detection of IschemiaNational Heart, Lung, and Blood Institute (NHLBI)Not Yet RecruitingEarly Phase 1
NCT07762495Not Yet Recruiting
Early Phase 1
Echocardiographic Molecular Imaging for POC Detection of IschemiaNational Heart, Lung, and...
NCT07763327
Effects of a Wearable Device ,Phone App and Exercise on Cervico-thoracic Posture in University Students.Riphah International UniversityNot Yet RecruitingNot Applicable
NCT07763327Not Yet Recruiting
Not Applicable
Effects of a Wearable Device ,Phone App and Exercise on Cervico-thoracic Posture...Riphah International Univ...
NCT07763353
Effects of Slow-paced Breathing on Heart Rate Variability in Patients With Heart FailureChung Shan Medical UniversityNot Yet RecruitingNot Applicable
NCT07763353Not Yet Recruiting
Not Applicable
Effects of Slow-paced Breathing on Heart Rate Variability in Patients With Heart...Chung Shan Medical Univer...
NCT07762924
Omission of Adjuvant Radiotherapy in Young Low-Risk Ductal Carcinoma In Situ Following Breast-Conserving SurgeryFudan UniversityRecruitingPhase 2
NCT07762924Recruiting
Phase 2
Omission of Adjuvant Radiotherapy in Young Low-Risk Ductal Carcinoma In Situ Fol...Fudan University
NCT07762378
Clinical Impact of a Machine Learning Decision Support System for Empirical Antibiotic TherapyInstituto de Investigación Sanitaria Gregorio MarañónNot Yet RecruitingNot Applicable
NCT07762378Not Yet Recruiting
Not Applicable
Clinical Impact of a Machine Learning Decision Support System for Empirical Anti...Instituto de Investigació...
NCT07761962
Laser Assisted Pulpotomy Versus MTA Pulpotomy in Permanent Teeth With Irreversible PulpitisKing Abdullah University HospitalActive Not RecruitingNot Applicable
NCT07761962Active Not Recruiting
Not Applicable
Laser Assisted Pulpotomy Versus MTA Pulpotomy in Permanent Teeth With Irreversib...King Abdullah University...
NCT07763938
CD19/CD20 Dual-Target in Vivo CAR-T Lentiviral Product in the Treatment of Relapsed/Refractory B-cell MalignanciesNanjing Legend Biotech Co.Not Yet RecruitingPhase 1
NCT07763938Not Yet Recruiting
Phase 1
CD19/CD20 Dual-Target in Vivo CAR-T Lentiviral Product in the Treatment of Relap...Nanjing Legend Biotech Co...
NCT07763990
THE EVALUATION OF THE SAFETY AND PERFORMANCE OF AN INJECTABLE HYALURONIC ACID FILLERHallura Ltd.RecruitingNot Applicable
NCT07763990Recruiting
Not Applicable
THE EVALUATION OF THE SAFETY AND PERFORMANCE OF AN INJECTABLE HYALURONIC ACID FI...Hallura Ltd.
NCT07762313
An Open-label Study to Assess the Safety and Efficacy of SYMVESS® as a Vascular Conduit in Adolescents With Extremity Arterial Injury.Humacyte, Inc.Not Yet RecruitingPhase 3
NCT07762313Not Yet Recruiting
Phase 3
An Open-label Study to Assess the Safety and Efficacy of SYMVESS® as a Vascular...Humacyte, Inc.
NCT07762261
Impact of Generative AI on University Students' Learning Processes and Critical ThinkingAtaturk UniversityNot Yet RecruitingNot Applicable
NCT07762261Not Yet Recruiting
Not Applicable
Impact of Generative AI on University Students' Learning Processes and Critical...Ataturk University
NCT07762560
Routine Microaxial Heart Pump Support and Protocolized Pulmonary Artery Catheter Monitoring Versus Standard Care in Heart Attack-Related Cardiogenic ShockBoston Scientific CorporationNot Yet RecruitingNot Applicable
NCT07762560Not Yet Recruiting
Not Applicable
Routine Microaxial Heart Pump Support and Protocolized Pulmonary Artery Catheter...Boston Scientific Corpora...
NCT07762040
Predictors of Progression Independent of Relapse Activity in Relapsing Remitting Multiple SclerosisAssiut UniversityNot Yet Recruiting
NCT07762040Not Yet Recruiting
—
Predictors of Progression Independent of Relapse Activity in Relapsing Remitting...Assiut University
NCT07764094
Impact of Procedural Factors on Drug-Coated Balloon Outcomes in Coronary Artery DiseaseNanjing First Hospital, Nanjing Medical UniversityRecruiting
NCT07764094Recruiting
—
Impact of Procedural Factors on Drug-Coated Balloon Outcomes in Coronary Artery...Nanjing First Hospital, N...
NCT07762001
Phase 1 Single-blind Placebo-controlled Dose Escalation Safety Study of AD-NP1Arjun Deb, MDActive Not RecruitingPhase 1
NCT07762001Active Not Recruiting
Phase 1
Phase 1 Single-blind Placebo-controlled Dose Escalation Safety Study of AD-NP1Arjun Deb, MD
NCT07763522
Validation of a Methodology Using Isometric Dynamometer for Ankle STrength Assessment to Quantify LDH-induced ParesisHelsinki University Central HospitalEnrolling By InvitationNot Applicable
NCT07763522Enrolling By Invitation
Not Applicable
Validation of a Methodology Using Isometric Dynamometer for Ankle STrength Asses...Helsinki University Centr...
NCT07762807
Colchicine And Dialysis Patients; a Feasibility StudyGuy's and St Thomas' NHS Foundation TrustRecruitingNot Applicable
NCT07762807Recruiting
Not Applicable
Colchicine And Dialysis Patients; a Feasibility StudyGuy's and St Thomas' NHS...
NCT07763236
Indocyanine Green Fluorescence in Endoscopic Resection of Non-Functioning Pituitary AdenomasTomislav FelbabićCompletedNot Applicable
NCT07763236Completed
Not Applicable
Indocyanine Green Fluorescence in Endoscopic Resection of Non-Functioning Pituit...Tomislav Felbabić
Result Breakdown
Not yet recruiting10 (50%)
Recruiting4 (20%)
Completed3 (15%)
Active, not recruiting2 (10%)
Enrolling by invitation1 (5%)
not_applicable13 (65%)
Phase 12 (10%)
Not Specified2 (10%)
Early Phase 11 (5%)
Phase 21 (5%)
Phase 31 (5%)